1. Prescribed drug spending in Canada, 2016; a focus on public drug programs;Canadian Institute for Health Information,2016
2. PMPRB guidelines modernization – discussion paper;Patented Medicine Prices Review Board,2016
3. Payers' experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia;Morgan;Health Policy,2017
4. Submission to the patendted medicine prices review board;Innovative Medicines Canada,2016
5. The economic case for universal pharmacare: costs and benefits of publicly funded drug coverage for all Canadians;Gagnon,2010